Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07356284 · ClinicalTrials.gov registry record · Phase 3
Emergent Large Vessel Occlusion Endovascular Rescue Therapy With Underlying Intracranial Stenosis
A Phase 3 study, sponsored by ProMedica Health System.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 342
- Enrollment target
NCT07356284: Recruiting Phase 3 study, sponsored by ProMedica Health System.
NCT07356284 is a Phase 3 study that is actively recruiting participants, run by ProMedica Health System. The registered enrollment target is 342 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (56% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07356284, a Phase 3 study, is actively recruiting participants, sponsored by ProMedica Health System.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 342 participants
- Enrollment target
Study Summary
The study objective is to establish the safety and efficacy of endovascular adjunct stenting for patients undergoing mechanical thrombectomy (MT) that are found to have residual stenosis (70-99%) following attempted clot retrieval with either aspiration catheters or stent retrievers, per device instructions for use and device labeling.
Primary Outcome
• Utility weighted 90-day Modified Rankin Score (mRS)
Interventions
- PROCEDURE Mechanical Thrombectomy plus adjunct stenting
- DEVICE Mechanical Thrombectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 342 participants |
| Start Date | 2026-05-19 |
| Est. Completion | 2030-06-01 |
| Phase | Phase 3 |
What NCT07356284 shows while recruiting
NCT07356284 is an interventional study that assigns participants to a tested intervention. The registered 342 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (56% lower).
The record links to 0 conditions, and to 2 interventions - of which Mechanical Thrombectomy plus adjunct stenting is the first listed.
NCT07356284 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07356284 about?
NCT07356284 is a clinical study titled "Emergent Large Vessel Occlusion Endovascular Rescue Therapy With Underlying Intracranial Stenosis". The study objective is to establish the safety and efficacy of endovascular adjunct stenting for patients undergoing mechanical thrombectomy (MT) that are found to have residual stenosis (70-99%) following attempted clot retrieval with either aspiration catheters or stent retrievers, per device inst...
What is the current status of trial NCT07356284?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 342 participants. The study started on 2026-05-19. Estimated completion is 2030-06-01.
What interventions are being tested in trial NCT07356284?
The interventions under investigation include: Mechanical Thrombectomy plus adjunct stenting (PROCEDURE), Mechanical Thrombectomy (DEVICE).
Who is sponsoring clinical trial NCT07356284?
This trial is sponsored by ProMedica Health System, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07356284's enrollment target sits among peer trials
342 1053rd of 2000 higher than 948 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05283850 · 342 participants · Phase 2
Surviving PEA in Roanoke (SPEAR) Study
- NCT05714085 · 342 participants · Phase 2
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- NCT06188702 · 342 participants · Phase 1
S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP
- NCT06544941 · 342 participants · NA
Improving Maternal Sleep and Mental Health
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI